Anthropic is running a lab that does biology experiments in the Bay Area
Eric Kauderer-Abrams, the company’s head of life sciences, confirmed it to Reuters and said the final test in biology is still real lab work. The goal is for Claude to direct automated lab equipment under human supervision. The lab sits on top of Coefficient Bio, bought in April for roughly $400 million in stock. Anthropic says the focus is fundamental biology rather than drug discovery, and has not disclosed the lab’s size, staff, opening date or biosafety level.
Sources
- Reuters, “Anthropic quietly sets up biology lab as it ramps AI drug program”, (reuters.com)
- TechCrunch, “Anthropic is operating a lab that conducts biology experiments”, (techcrunch.com)
- The Next Web, “Anthropic has quietly built a biology lab, Reuters reports”, (thenextweb.com)
- TechCrunch, “Anthropic buys biotech startup Coefficient Bio in $400M deal: Reports”, (techcrunch.com)
About this story
Spotted an error in this story? [email protected] · Instagram
Short link: thejarrus.com/en/anthropic-biology-lab
This story in Turkish: Anthropic, Bay Area’da biyoloji deneyleri yapan bir laboratuvar işletiyor
On the same topic
Robot tests: even the best model completed only 19% of 84 robot tasks, and 63 tasks were solved by no model
In RobotWorld, a benchmark released October 7, the top model, GPT-6 Astra, completed only 16 of 84 simulated robot tasks; no model solved 63 of the tasks.
OpenAI’s image model posts a near-perfect score on text-dense images
On UltraText Bench, a dense-text test led by Westlake University, OpenAI’s GPT Image 2 ranked first of 24 configurations with 99.35 out of 100.
DeepMind-born drug discovery company Isomorphic Labs in funding talks at a $40-50 billion valuation
Isomorphic Labs, the DeepMind-born AI drug discovery company, is in early talks to raise money at a valuation of at least $40 billion, Bloomberg reported.